Stock 1SXP SCHOTT PHARMA AG & CO. KGAA
Add to a list
To use this feature you must be a member
Log inSign up

Financials SCHOTT Pharma AG & Co. KGaA Deutsche Boerse AG

Equities

1SXP

DE000A3ENQ51

Medical Equipment, Supplies & Distribution

Market Closed - Deutsche Boerse AG
Other stock markets
 16:00:15 31/05/2024 BST 		5-day change 1st Jan Change
29.28 EUR +3.24% Intraday chart for SCHOTT Pharma AG & Co. KGaA -4.00% -13.37%
05-28 SCHOTT PHARMA : Berenberg reiterates its Neutral rating ZD
05-21 Deutsche Bank Research lowers target for Schott Pharma - 'Buy' DP

Valuation

Fiscal Period: September 2023 2024 2025 2026
Capitalization 1 4,765 4,413 - -
Enterprise Value (EV) 1 4,914 4,613 4,601 4,542
P/E ratio 31.3 x 30.4 x 26.6 x 20.3 x
Yield 0.47% 0.53% 0.62% 0.77%
Capitalization / Revenue 5.3 x 4.52 x 4.01 x 3.51 x
EV / Revenue 5.47 x 4.72 x 4.18 x 3.61 x
EV / EBITDA 20.6 x 18.1 x 15.2 x 12.1 x
EV / FCF 491 x -266 x 160 x 64.6 x
FCF Yield 0.2% -0.38% 0.63% 1.55%
Price to Book 7.23 x 5.4 x 4.57 x 3.84 x
Nbr of stocks (in thousands) 150,615 150,615 - -
Reference price 2 31.64 29.30 29.30 29.30
Announcement Date 26/01/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2022 2023 2024 2025 2026
Net sales 1 821 898.6 976.5 1,100 1,258
EBITDA 1 219 239 254.9 303.7 376
EBIT 1 - 192.4 190.9 219.2 283
Operating Margin - 21.41% 19.55% 19.93% 22.49%
Earnings before Tax (EBT) 1 - 185.8 182.7 221.7 278.4
Net income 1 - 151.8 144.2 166.6 221.6
Net margin - 16.9% 14.76% 15.15% 17.61%
EPS 2 - 1.010 0.9651 1.099 1.443
Free Cash Flow 1 - 10 -17.32 28.76 70.35
FCF margin - 1.11% -1.77% 2.62% 5.59%
FCF Conversion (EBITDA) - 4.18% - 9.47% 18.71%
FCF Conversion (Net income) - 6.59% - 17.27% 31.75%
Dividend per Share 2 - 0.1500 0.1558 0.1820 0.2260
Announcement Date 26/01/23 26/01/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: Settembre 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 228.5 232.3 234.3 222.9 287.3 - -
EBITDA 1 51.64 72.7 55.8 66.08 65.34 - -
EBIT 1 37.78 58.03 34.73 38.51 50.38 - -
Operating Margin 16.53% 24.99% 14.82% 17.27% 17.54% - -
Earnings before Tax (EBT) - - - - - - -
Net income 1 34.7 44.41 17.33 29.61 37.07 - -
Net margin 15.18% 19.12% 7.39% 13.28% 12.9% - -
EPS 2 0.2300 0.2900 0.2072 0.2030 0.2447 - -
Dividend per Share 2 - - - - 0.1570 - -
Announcement Date 26/01/24 01/03/24 - - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: Settembre 2022 2023 2024 2025 2026
Net Debt 1 - 148 200 188 129
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) - 0.621 x 0.7863 x 0.6197 x 0.3443 x
Free Cash Flow 1 - 10 -17.3 28.8 70.4
ROE (net income / shareholders' equity) - 21.7% 19% 19.1% 20.2%
ROA (Net income/ Total Assets) - 12.5% 10.3% 11% 12.5%
Assets 1 - 1,214 1,393 1,519 1,767
Book Value Per Share 2 - 4.380 5.430 6.420 7.640
Cash Flow per Share 2 - 1.210 1.360 1.640 1.890
Capex 1 - 175 216 198 186
Capex / Sales - 19.53% 22.1% 18% 14.81%
Announcement Date 26/01/23 26/01/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for SCHOTT Pharma AG & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
29.3 EUR
Average target price
34.84 EUR
Spread / Average Target
+18.90%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ABBOTT LABORATORIES Stock Abbott Laboratories
-7.16% 178B
MEDTRONIC PLC Stock Medtronic plc
-1.23% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.86% 67.04B
DEXCOM, INC. Stock DexCom, Inc.
-4.28% 47.23B
CENCORA, INC. Stock Cencora, Inc.
+10.32% 44.62B
HOYA CORPORATION Stock Hoya Corporation
+8.14% 42.5B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+15.76% 29.99B
TERUMO CORPORATION Stock Terumo Corporation
+15.53% 25.22B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-5.88% 24.14B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 1SXP Stock
  4. 1SXP Stock
  5. Financials SCHOTT Pharma AG & Co. KGaA